Polycystic Ovary Syndrome Gets a New Name — Why It Matters

For years, polycystic ovary syndrome was one of the most common but misunderstood hormonal conditions affecting women and people assigned female at birth. The name made it sound like the main problem was ovarian cysts, yet many patients never had true cysts, and many of the most life-changing effects were metabolic, hormonal, psychological, dermatological, and reproductive.

Now, after a 14-year global effort involving more than 50 patient and professional organisations, PCOS has been officially renamed Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The change is not just cosmetic. It is meant to correct a misleading label, improve diagnosis, reduce stigma, and push doctors to treat the condition as a whole-body endocrine and metabolic disorder, not simply a fertility or ovary issue.